The University of Texas MD Anderson Cancer Center IOTOX Symposium Treating Immune-Related Adverse Events Integrating Insights from Clinical, Translational and Basic Science 2024

The IOTOX Symposium is designed to bring a diverse range of stakeholders together to foster collaboration, share cutting-edge research findings, and discuss treatment advancements in the field of immunotherapy toxicities. The Symposium will provide a platform for attendees to engage in in-depth discussions and attend presentations that highlight new methodologies, emerging technologies, and innovative clinical management strategies. By facilitating network and knowledge exchange, the Symposium seeks to drive scientific progress and translate research into practical treatment options to improve patient outcomes.

Call for Abstracts
We invite faculty, trainees and staff to submit abstracts in the areas of clinical, translational, and basic science research. Submission deadline has been extended. To be considered for oral presentation, submit by Sunday, Sept. 29, 11:59pm.

1. Construct the guideline recommendations for each toxicity.
2. Identify location and use of national societies guidelines for IOTOX.
3. Implement IOTOX guidelines that are vetted by both oncologists and internal medicine specialists.
4. Identify patient treatment plans to evaluate difficult patient circumstances as it pertains to IOTOX.
5. Employ treatment plans and IOTOX guidelines to all providers including Pharmacists, APPs, Nurses and Trainees.